1. Validation of the all-comers design: Results of the TARGET-AC substudy
- Author
-
Christoph J Jensen, Lene Holmvang, Jose Sevilla, Luc Maillard, Ferdinand Kiemeneij, Luc Janssens, Salvatore Brugaletta, Anastasios Milkas, Henning Kelbæk, Christoph Naber, Peter Nørkjær Laursen, Felix Pucher, William Wijns, Emanuele Barbato, Alexandra Lansky, Koen Ameloot, Carlos Robles, Gabor G. Toth, Andreas Baumbach, Niels van Royen, Cardiology, ACS - Atherosclerosis & ischemic syndromes, G Toth, G., Lansky, A., Baumbach, A., Kelbaek, H., van Royen, N., Holmvang, L., Janssens, L., Brugaletta, S., Barbato, E., Maillard, L., Kiemeneij, F., Naber, C. K., Pucher, F., Laursen, P. N., Ameloot, K., Robles, C., Milkas, A., Sevilla, J., Jensen, C., and Wijns, W.
- Subjects
Male ,medicine.medical_specialty ,Patient demographics ,Population ,Context (language use) ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Percutaneous Coronary Intervention ,medicine ,Humans ,In patient ,030212 general & internal medicine ,Angina, Stable ,Prospective Studies ,Registries ,Acute Coronary Syndrome ,education ,Non-ST Elevated Myocardial Infarction ,Sampling bias ,Aged ,Protocol (science) ,education.field_of_study ,business.industry ,Patient Selection ,Coronary Stenosis ,Vascular damage Radboud Institute for Molecular Life Sciences [Radboudumc 16] ,Drug-Eluting Stents ,Middle Aged ,Clinical trial ,Clinical research ,Research Design ,Emergency medicine ,ST Elevation Myocardial Infarction ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Item does not contain fulltext BACKGROUND: Results of clinical trials are often criticized by low inclusion rate and potential sampling bias in patient recruitment. The aim of this validation registry is to evaluate how far an all-comers design in the context of clinical research can ensure the representation of the true all-comers population. METHODS: This validation registry is a prospective international multicentre registry, conducted at 10 out of the total 21 centers, participating in TARGET-AC (registered under NCT02520180). During a predefined four-week period data were recorded prospectively on all PCIs performed in the participating centers, whether or not patients were enrolled in TARGET-AC. Data were collected on patient demographics, angiographic lesion- and procedural characteristics. For patients who were not enrolled in the study, operators were asked to declare the reason for not enrolling the patient, using a single-choice questionnaire. RESULTS: A total of 131 patients were enrolled in the TARGET-AC study during the investigated period (ER group), standing as 20% (range 4% and 54%) of all eligible cases per protocol. In the ER group more patients presented with stable angina (61% vs. 43%, respectively; P
- Published
- 2020
- Full Text
- View/download PDF